Compounds > cidofovir anhydrous
Page last updated: 2024-08-24

cidofovir anhydrous and Graft vs Host Disease

cidofovir anhydrous has been researched along with Graft vs Host Disease in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (66.67)29.6817
2010's2 (16.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Cao, J; Chen, F; Wu, D; Wu, Q; Wu, Y; Zhang, Y; Zhao, Y; Zhou, J1
Atsuta, Y; Eto, T; Fukuda, T; Hirakawa, A; Ichinohe, T; Ikegame, K; Inamoto, Y; Inoue, M; Kimura, T; Kuwatsuka, Y; Miyamura, K; Najima, Y; Okamoto, S; Ozawa, Y; Uchida, N1
Ader, F; Barraco, F; Billaud, G; Chidiac, C; Detrait, M; Ducastelle-Leprêtre, S; Ferry, T; Gilis, L; Labussière-Wallet, H; Michallet, M; Morisset, S; Nicolini, FE; Salles, G; Sobh, M; Tedone, N; Thomas, X1
Bilius, V; Pasauliene, R; Rageliene, L; Rascon, J; Verkauskas, G; Zubka, V1
Benninghoff, U; Friedrich, W; Hönig, M; Schulz, A; Schütz, C1
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J1
Bailey, AS; Carr, TF; Coussons, M; Grainger, JD; Guiver, M; Khalid, T; Mutton, KJ; Sivaprakasam, P; Turner, AJ; Wynn, RF1
Bornhäuser, M; Ehninger, G; Illmer, T; Jacobs, E; Kiani, A; Pöhlmann, C; Reuner, U; Rohayem, J; Schetelig, J1
Boeckh, M; Chuang, EL; Corey, L; Crippa, F; Sale, G1
Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B1
Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H1

Reviews

1 review(s) available for cidofovir anhydrous and Graft vs Host Disease

ArticleYear
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:9

    Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning

2003

Other Studies

11 other study(ies) available for cidofovir anhydrous and Graft vs Host Disease

ArticleYear
Adenovirus infection diagnosed by metagenomic next-generation sequencing after haploidentical hematopoietic stem cell transplantation: A multicenter study in China.
    Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25, Issue:2

    Topics: Adenoviridae Infections; Cidofovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; High-Throughput Nucleotide Sequencing; Humans; Immunoglobulins, Intravenous; Retrospective Studies

2023
Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection.
    International journal of hematology, 2020, Volume: 112, Issue:6

    Topics: Acute Disease; Adult; Beclomethasone; Chronic Disease; Cidofovir; Cytomegalovirus Infections; Etanercept; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Japan; Male; Middle Aged; Mycophenolic Acid; Off-Label Use; Postoperative Complications; Registries; Transplantation, Homologous; Virus Diseases

2020
High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2014, Volume: 49, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; BK Virus; Cidofovir; Cystitis; Cytosine; Female; Graft vs Host Disease; Health Care Costs; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Costs; Humans; Incidence; Male; Middle Aged; Organophosphonates; Polyomavirus Infections; Risk Factors; Transplantation, Homologous; Tumor Virus Infections; Viremia; Young Adult

2014
Intravesical cidofovir to treat BK virus-associated hemorrhagic cystitis in children after hematopoietic stem cell transplantation.
    Pediatric transplantation, 2015, Volume: 19, Issue:4

    Topics: Administration, Intravesical; Adolescent; Antiviral Agents; BK Virus; Child; Cidofovir; Cystitis; Cytosine; Female; Formaldehyde; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemorrhage; Humans; Immune System; Male; Organophosphonates; Polymerase Chain Reaction; Polyomavirus Infections; Time Factors

2015
Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.
    Immunologic research, 2009, Volume: 44, Issue:1-3

    Topics: Antiviral Agents; Child; Child, Preschool; Chimerism; Cidofovir; Cyclosporine; Cytosine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Organophosphonates; Treatment Failure; Wiskott-Aldrich Syndrome

2009
Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2

    Topics: Adenovirus Infections, Human; Adolescent; Antiviral Agents; Blood; Bronchoalveolar Lavage Fluid; Child; Cidofovir; Cytosine; Feces; Female; Fluorescent Antibody Technique; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Infant; Male; Microscopy, Electron, Transmission; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin

2007
Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jun-15, Volume: 44, Issue:12

    Topics: Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Organophosphonates; Roseolovirus Infections; Viral Load

2007
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jan-15, Volume: 32, Issue:2

    Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Treatment Outcome; Virus Activation

2001
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Pathologie-biologie, 2001, Volume: 49, Issue:7

    Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation

2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation

2001
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting

2001